EMA Orphan Drug Designation (ODD) builds on U.S. Food Drug Administration (FDA) ODD and Fast Track Designation, underscoring the urgent need for new treatment optionsThe multiple regulatory…Read More
You might also be interested in reading Warsh Tells the Senate Trump Never Asked for a Rate Cut Commitment and He Would Have Refused.